Amedisys has been among the many home health and hospice providers taking financial and operational hits as the coronavirus pandemic continues its spread, Hospice News reports. Despite facing headwinds, the company remains steadfast in its position on hospice as it seeks to further build up its presence in the market. Read more.
Related Posts
Epic Research Shows Telehealth Efficacy, Makes Case for More Reimbursement
To determine which specialties were able to fulfill patient needs using telehealth and which required in-person follow-up visits more often, two teams of researchers examined more than 35 million telehealth visits conducted between March 1, 2020, and May 31, 2022.
December 16, 2022
Primary Care: Health Investors Bet Billions on Medicine’s Worst-Paying Specialty
U.S. companies focused on primary care raised about $16 billion from investors in 2021. That’s more than four times the amount invested in 2020.
February 11, 2022
Female physicians more likely to adopt telehealth early
"Some physicians may have been nimbler than others in making the transition [to telehealth], potentially influencing patients' experience of physician access and availability," wrote the research team.
January 6, 2022
Physician-Owned Hospitals Remain Prime Targets Amid Changing Landscape
The market has demonstrated that there is significant strategic value in partnering with physician-owned and led organizations.
July 27, 2021